Molecular Cancer Therapeutics
Source
ISSNs 1535-7163, 1538-8514
Source type: journal
Publisher: American Association for Cancer Research
Alternate names Mol Cancer Ther, MCT
Fully open access: No
In DOAJ: No
2yr mean citedness: 1.816
H-index: 216
I10-index: 5,269
Works count: 6,886
Citations count: 336,400
PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy
2015 · Sandip Pravin Patel, Razelle Kurzrock · Molecular Cancer Therapeutics
Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers
2017 · Aaron M. Goodman, Shumei Kato, et al. · Molecular Cancer Therapeutics
Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling
2008 · Scott M. Wilhelm, Lila Adnane, et al. · Molecular Cancer Therapeutics